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Background
Breast cancer is the most common cancer in females worldwide, and radiotherapy (RT) 
is a vital component in breast cancer management (Overgaard et al. 1997; Ragaz et al. 
1997). There are various methods to employ radiotherapy for breast cancer. For example, 
three dimensional conformal radiotherapy (3DCRT) using wedged tangential fields after 
breast-conserving surgery improves disease control and breast-cancer related survival. 
3DCRT reduces normal tissue doses and increases conformity to target volume.
Abstract 
The aim of this study was to identify a rational strategy for the selection of multi-beam 
IMRT in patients with right breast cancer through the comparison of dosimetric param-
eters of the planning target volume (PTV) and organs at risk (OARs) using five different 
radiotherapy modalities. This was a retrospective study using computed tomography 
scans from ten patients with early-stage right breast cancer who had been treated 
previously. Three dimensional conformal radiotherapy (3DCRT), forward-planned IMRT 
(for-IMRT), inverse-planned IMRT (inv-IMRT), helical tomotherapy (HT), and volumetric-
modulated arc therapy (VMAT) were planned for each patient. The plans were com-
pared according to dose–volume histogram analysis. The most significant impact of 
inverse-planned multi-beam modalities for right breast cancer was the reduction of 
Dmax, Dmean, V53.5 and prescribed dose volume (cc) outside of the PTV (breast) (OB-
V50) of the PTV. HT decreased the ipsilateral OAR volumes receiving higher doses. In 
exchange, HT also increased the volumes receiving low doses, which is known to lead 
to an increased rate of radiation-induced secondary malignancies. The heart, LAD, and 
contralateral doses for 3DCRT and for-IMRT were significantly lower than those for 
inv-IMRT, HT, and VMAT. In addition, inv-IMRT demonstrated an increase in exposed 
volume of heart, LAD, ipsilateral lung, and contralateral lung compared with those 
parameters for HT or VMAT. Although it is known to reduce cardiac toxicity with breath 
hold technique in left sided breast cancer, similarly it is possible for 3DCRT and for-IMRT 
techniques in right sided breast cancer even in free breathing.
Keywords: Doses to the heart and LAD, Helical tomotherapy, Multi-beam inverse 
planning, Right breast cancer, Volumetric arc therapy
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With the advent of advanced sophisticated treatment planning software and multi-
leaf collimators (MLC), intensity-modulated radiotherapy (IMRT) is becoming increas-
ingly popular and widely used for the treatment of breast carcinoma. IMRT is thought 
to result in a preferred dose distribution compared to 3DCRT after conservative surgery 
or mastectomy (Cozzi et al. 2005; Fong et al. 2009; Johansen et al. 2009; Vatanen et al. 
2009). The IMRT allows the user to modulate the intensity of each radiation beam, so 
each field may have one or many areas of high intensity radiation and any number of 
lower intensity areas within the same field.
The result is greater control of the dose distribution within the target area. To date, 
several publications have reported that IMRT, including forward-planned field-in-field 
IMRT (for-IMRT), inverse-planned IMRT (inv-IMRT), and helical tomotherapy (HT), 
results in a preferred dose distribution compared to 3DCRT for the RT of breast can-
cer (Barnett et al. 2009; Zhang and Zheng 2011). However, there have been conflicting 
reports on the performance of for-IMRT, inv-IMRT, and HT, and it is unclear which of 
these techniques is superior (Caudrelier et al. 2009; Moon et al. 2009; Coon et al. 2010; 
Gauer et al. 2010; Hijal et al. 2010; Qiu et al. 2013). Moreover, most of these studies have 
examined left-sided breast irradiation, and relatively little literature exists evaluating 
right-sided whole breast irradiation.
Dosimetric benefit of IMRT has been established for left breast cancer (Barnett et al. 
2009; Zhang and Zheng 2011; Haciislamoglu et  al. 2015). However, IMRT is not rou-
tinely employed for right breast cancer. In this study, we retrospectively analyzed the 
dosimetric and technical differences among 3DCRT, for-IMRT, inv-IMRT, HT, and 
volumetric-modulated arc therapy (VMAT) in 10 patients with right-sided breast can-
cer who had received conservative surgery and were previously irradiated with 3DCRT 
or for-IMRT. We quantitatively compared the quality of treatment plans according to 
dose uniformity and conformity in breast volume. We also examined the dose to the sur-
rounding normal tissues of lungs, heart, left anterior descending artery (LAD) and con-
tralateral breast.
Methods
Patient selection, positioning, and computed tomography scanning
Ethics committee approval was received for this study from the ethics committee of 
Karadeniz Technical University, Farabi Hospital. This study was conducted using treat-
ment plans done on the computed tomography (CT) simulation data sets (5 mm slice 
thickness) of 10 consecutive right-sided breast cancer patients who had been previously 
treated with T1N0 carcinoma at our clinic. Patients were placed in the supine position 
on a breast board with ipsilateral arm raised above the head. Patients were scanned with 
coverage of all the inferior, superior, and lateral borders of the whole breast and critical 
organs. After the planning CT was done, the Digital Imaging and Communication in 
Medicine (DICOM) images were transferred to the Eclipse (version 10, Varian Medical 
Systems) treatment planning system (TPS).
Target and organ at risk delineation
Auto contouring was used on the body and both lungs. The delineation of target and crit-
ical structures (heart, LAD, and the contralateral breast) for all patients was determined 
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by a single radiation oncologist with extensive experiences in the treatment of breast 
cancer to prevent personal contouring differences that could skew the study results. The 
clinical target volume (CTV) was defined as the glandular breast tissue apparent on the 
CT scan. The PTV was determined as the CTV retracted 5 mm from the skin surface 
(Schubert et al. 2011). The purpose of this retraction was to account for dose buildup 
during dose calculation. For this reason, the PTV was used for target coverage com-
parisons. A new planning volume, the PTV-IMRT, was defined to facilitate inv-IMRT 
planning optimization, and this planning volume was created with a margin of 5  mm 
on the breast PTV to assure coverage of the treatment area (Mayo et al. 2005; Schubert 
et al. 2011). The organs at risk (OARs) included the ipsilateral lung (IL), the contralateral 
lung (CL), the heart, LAD, and the contralateral breast (CB). The LAD was contoured 
by the reference of RTOG organ at risk atlas. The CTV, PTV, and OARs were gener-
ated in accordance with the Radiation Therapy Oncology Group (RTOG) 0319 protocol 
(D’Arienzo et al. 2012).
An additional structure, which was specified as Body-PTV, was created to evaluate the 
effects of low doses on the body excluding the PTV. With the use of anatomic references, 
Body-PTV was defined superiorly at the T1 thoracic vertebrae level and inferiorly at the 
L1 lumbar vertebrae level. Boolean operations were used to construct a modified body 
volume that excluded breast tissue with a 1-cm margin. CT images of each patient with 
complete target and organ structure information were transferred into the tomotherapy 
planning systems.
Treatment planning details and dose prescription
All 3DCRT, for-IMRT, inv-IMRT and VMAT plans were designed on the Eclipse plan-
ning system (version 10), while HT planning was conducted on the Hi-Art (version 4.1.2) 
treatment planning system. All treatment plans were generated with 6 MV (Mega volt-
age) photon beams to maintain the comparison between the five treatment techniques. 
The Pencil Beam Convolution algorithm was used to calculate the optimal dose for all 
plans. The prescribed dose to the PTV was 50 Gy in 2 Gy daily fractions. The treatment 
plans were optimized to meet the planning objectives and to achieve the prescribed dose 
delivery for > 90 % of the prescribed isodose (45 Gy) to encompass greater than 95 % of 
the PTV volume. The dose–volume constraints used for the targets and critical struc-
tures are listed in Table 1. These constraints were based on experience in our clinic and 
kept the same for all plans.
Forward‑planned modalities (3DCRT and for‑IMRT)
For the 3DCRT technique, the beam arrangement consisted of two parallel opposing tan-
gential beams to ensure the best possible coverage of the breast tissue and to minimize 
the dose to the adjacent critical structures. The “isocenter” of the treatment machine 
was positioned at the center point of the midline that joins two parallel opposing fields. 
Dynamic wedges were then added to both tangential beams in order to improve the dose 
uniformity to the PTV. The for-IMRT technique used two tangential fields with the same 
beam angles and same isocenter point as that used for 3DCRT, and 2- to 4-segment 
field-in-field modulation was used to homogenize the breast dose for each field.
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Inverse‑planned modalities (inv‑IMRT, HT, and VMAT)
For inv-IMRT, nine beams with different gantry angles were defined and optimized to 
meet the requirements established for irradiating the PTV and sparing the OARs. The 
lateral and medial gantry angles were the same as those used for 3DCRT and for-IMRT, 
and the other seven fields were placed between these fields at equal intervals. The “iso-
center” of the treatment machine was positioned at the same point as that used for the 
3DCRT and for-IMRT plans. For HT, the parameters affecting dose conformity and treat-
ment times are the field width (FW), pitch, and modulation factor (MF). This study uti-
lized a 2.5-cm FW, a pitch of 0.287 and an MF of 2.5. The virtual structure (constraint 
heart and LAD) for dose constraint was contoured for each patient to increase the dose 
conformity of the PTV and to decrease the dose to the lungs, LAD, and heart. Directional 
or partial blocking was applied to the virtual structure and partial blocking was applied to 
the CB. Critical structures and virtual structure volume dose constraints were set in the 
optimization procedure. For the VMAT plan, a partial arc arrangement was selected in 
order to minimize dose to the normal structures. The first step was to determine the par-
tial arc range based on the PTV location. Starting and ending beam angles of the arc were 
10 degrees posterior to the tangential fields used for 3DCRT and for-IMRT.
Plan comparisons
Dosimetric comparisons of the plans were performed based on the following parameters 
extracted from the dose–volume histogram (DVH): Dmax and Dmean of PTV (Dmax = dose 
received by 0.1 % volume of PTV, Dmean = mean dose of PTV), V53.5 (relative volume 
of breast PTV receiving 107 % of the prescription dose), IB-V50Gy (prescribed dose vol-
ume (cc) inside of the PTV), OB-V50Gy (prescribed dose volume (cc) outside of the PTV), 
conformation number (CN) and homogeneity index (HI). Additionally, dose and volume 
parameters of the OARs were examined. For all treatment plans, the DVH of the normal 
tissue-sparing (Body-PTV) and monitor unit (MU) settings required for each plan were 
calculated and compared.
HI was calculated from the following formula:
HI = (D2 − D98/D50)× 100 %
Table 1 Dose–volume constraints for target and organs at risk (OARs)
Target or OAR Goal or constraint dose (%)
Planning target volume (PTV) 45 or 47.5 Gy
Heart V20 < 10 %
V30 < 3 %
LAD Dmax < 15 Gy
Dmean < 5 Gy
Ipsilateral lung V20 < 20 %
V50 = 0
Contralateral lung V5 < 20 %
V10 = 0
Contralateral breast Dmean < 4 Gy
Dmax < 10 Gy
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where D98 =  the corresponding dose for 98  % of the target volume measured on the 
DVH, and D2 = the corresponding dose for 2 % of the volume on the DVH. The HI for-
mula shows that lower HI values indicate a more homogeneous target dose.
The CN value was calculated as previously proposed by Van’t Riet et al. (1997). This 
CN simultaneously takes into account irradiation of the target volume and irradiation of 
the healthy tissues. CN is calculated from the following formula:
where TVRI = target volume covered by the reference isodose (95 % of the prescribed 
dose), TV = target volume, and VRI = volume of the reference isodose. The CN ranges 
from 0 to 1, where 1 is the ideal value.
Statistical analysis
Statistical analysis was performed using SPSS software (version 13.0). Quantitative data 
were expressed as mean ± standard deviation (x ± SD). Multiple groups of means were 
compared with 1-way analysis of variance (ANOVA), after testing for equality of var-
iance. The 2–2 comparisons were calculated using the Bonferroni test between any 2 
means. A value of p ≤ 0.05 was considered statistically significant.
Results
Comparison of Dmax, Dmean, CN, HI and MU for different techniques
Dose–volume histogram plot of the five modalities for a typical patient for PTV is illus-
trated in Fig. 1. All of the evaluated modalities provided adequate coverage of the whole 
breast (95 % of the PTV, or ideally 47.5 Gy, but at least 45 Gy). The Dmax, Dmean, V53.5 (%), 
IB-V50Gy, OB-V50Gy, CN, HI, and MU of all 5 techniques are summarized in Table 2.
CN = (TVRI/TV)(TVRI/VRI)
Fig. 1 Dose–volume histograms of the five modalities for a typical patient are shown for planning target 
volüme
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Significant differences in Dmax were found by 1-way ANOVA (p < 0.001). Further, the 
Bonferroni analysis showed that HT yielded significantly smaller values than 3DCRT, 
for-IMRT, and VMAT (p < 0.001, p = 0.040, p < 0.001), but no significant differences 
were observed between HT and inv-IMRT (p = 0.922). The Dmean was significantly dif-
ferent among the 5 techniques (p = 0.019), and Bonferroni analysis indicated that there 
was a significant difference in Dmean between HT and 3DCRT only (p = 0.002). Notably, 
HT showed the smallest values for Dmax and Dmean among all techniques.
To evaluate the maximum doses for the PTV, the parameter V53.5 was used. V53.5 was 
1.85 ±  1.77 % for inv-IMRT and 0.39 ±  0.59 % for HT, and these values were signifi-
cantly different than those of other modalities. For IB-V50Gy, there was no significant dif-
ference between groups (p = 0.964). The inv-IMRT, HT, and VMAT plans significantly 
reduced OB-V50Gy.
The difference in HI was statistically significant among the 5 techniques (p < 0.001), 
and Bonferroni analysis indicated that there were no significant differences between 
3DCRT and for-IMRT (p = 0.085). However, inv-IMRT and HT provided significantly 
superior uniformity over the other techniques (p < 0.001). VMAT plans had less homo-
geneity than inv-IMRT or HT. Differences in CN among the 5 techniques were statisti-
cally significant (p < 0.001), and Bonferroni analysis revealed that HT yielded superior 
CN compared with the other 4 types of techniques (average values closer to the ideal). 
Meanwhile, no significant difference was observed between 3DCRT and for-IMRT 
(p = 0.476) or between inv-IMRT and VMAT (p = 1.000).
In general, the inverse-planned modalities showed an increase in MU compared 
with forward-planned modalities. However, the MU of the VMAT plan (300  ±  52 
MU) was significantly smaller than that of the inv-IMRT (1245 ± 146 MU) and the HT 
(9284 ± 354 MU).
Comparison of the dosimetric parameters of OARs for different techniques
The DVH plots for OAR’s of the five modalities are depicted in Fig. 2. The dosimetric 
parameters of the OARs are listed in Table 3.
The 3DCRT and for-IMRT plans achieved similar sparing of the heart and LAD. 
Between forward and inverse-planned modalities, significant differences were uncovered 
Table 2 Comparision of target coverage metrics for the PTV as a function of plan modality 
(x  ± SD)
Dmax max dose, Dmean mean dose, Vx volume (%) receiving x dose (Gy) or higher, IB-V50Gy prescribed dose volume (cc) inside 
of the PTV, OB-V50Gy prescribed dose volume (cc) outside of the PTV, x mean dose, SD standard deviation, CN conformation 
number, HI homogeneity index, MU monitor unit
Metric 3DCRT for‑IMRT inv‑IMRT HT VMAT p‑value
Dmax (Gy) 55.94 ± 1.34 55.01 ± 1.30 54.16 ± 0.54 53.85 ± 0.66 55.08 ± 0.72 <0.001
Dmean (Gy) 51.86 ± 1.04 51.66 ± 1.00 51.18 ± 0.36 50.85 ± 0.22 51.35 ± 0.40 0.019
V53.5 (%) 20.56 ± 15.60 13.03 ± 12.80 1.85 ± 1.77 0.39 ± 0.59 10.15 ± 2.98 <0.001
IB-V50Gy (cc) 765 ± 338 659 ± 423 696 ± 314 750 ± 376 717 ± 399 0.964
OB-V50Gy (cc) 379 ± 323 245 ± 239 103 ± 58 76 ± 51 57 ± 29 <0.001
CN 0.58 ± 0.07 0.62 ± 0.08 0.75 ± 0.05 0.80 ± 0.05 0.73 ± 0.06 <0.001
HI 0.13 ± 0.02 0.12 ± 0.07 0.09 ± 0.01 0.06 ± 0.01 0.17 ± 0.02 <0.001
MU 231 ± 29 MU 222 ± 14 MU 1245 ± 146 MU 9284 ± 354 MU 300 ± 52 MU <0.001
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between the Dmax, Dmean, and V5 of the heart, and the Dmax and Dmean of LAD. These 
results are summarized in Table 4. for-IMRT and 3DCRT spared a greater heart volume 
than inverse-planned modalities (V5 = V10 = 0 for 3DCRT and for-IMRT), and the dif-
ferences between HT, inv-IMRT, and VMAT were not significant (Table 4). HT showed 
superior sparing of the heart compared with inv-IMRT and VMAT; however, no signifi-
cant differences were found between inv-IMRT, VMAT, and HT. 
The Dmax of the LAD was significantly different between the 5 techniques (p < 0.001). 
Further statistical analysis revealed that VMAT yielded smaller Dmax values than inv-
IMRT and HT, and no significant difference between inv-IMRT and HT was observed. 
Inverse-planned modalities resulted in the lowest maximum dose and the largest low-
dose volume in the ipsilateral lung compared to 3DCRT and for-IMRT. The ipsilateral 
lung mean dose was higher for inv-IMRT and VMAT than for 3DCRT and for-IMRT, 
but this dose was significantly lower for HT than for 3DCRT or for-IMRT.
Fig. 2 Dose–volume histograms of the five modalities for a typical patient are shown for a heart, b left ante-
rior descending artery (LAD), c ipsilateral lung, d contralateral lung, e contralateral breast, and f Body-PTV
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Contralateral lung mean and maximum doses were higher for all inverse-planned 
modalities. The relative volume of contralateral breast that received the mean, maxi-
mum, and low doses was significantly lower for forward planned tangential fields (FPTF) 
plans than for inverse planned multi-beam (IPMB) modalities. HT demonstrated an 
increase in the exposed volume of contralateral breast V3 and V5 values compared with 
inv-IMRT and VMAT. The three IPMB techniques examined exhibited statistically sig-
nificant differences in Body-PTV compared to the FPTF modalities. inv-IMRT involved 
the greatest spread of mainly low doses to the Body-PVT (verified by V3 and V5 in 
Table 3), whereas 3DCRT and for-IMRT had the lowest values for Body-PTV (expect for 
the fraction of Body-PTV volume receiving >30 Gy).
Discussion
Thousands of women who are diagnosed with breast cancer each year receive breast-
conserving surgery followed by adjuvant radiation therapy. Over the past decade, there 
has been a rapid rise in the application of advanced radiation delivery technologies and 
Table 3 Comparision of dosimetric metrics of OARs as a function of plan modality (x  ± SD)
Dmax max dose, Dmean mean dose, Vx volume (%) receiving x dose (Gy) or higher
Metric 3DCRT for‑IMRT inv‑IMRT HT VMAT p‑value
Heart (RB)
 Dmax (Gy) 2.73 ± 0.56 2.73 ± 0.52 17.80 ± 5.46 15.65 ± 3.38 12.87 ± 2.15 <0.001
 Dmean (Gy) 0.95 ± 0.17 0.93 ± 0.15 5.10 ± 1.20 3.74 ± 0.92 4.99 ± 0.76 <0.001
 V5 (%) 0.0 ± 0.0 0.0 ± 0.0 39.50 ± 19.02 27.60 ± 15.16 38.00 ± 12.10 <0.001
 V10 (%) 0.0 ± 0.0 0.0 ± 0.0 7.00 ± 4.26 3.50 ± 3.42 3.90 ± 2.95 <0.001
LAD (RB)
 Dmax (Gy) 1.00 ± 0.13 1.01 ± 0.16 8.10 ± 3.42 6.54 ± 1.85 4.63 ± 0.83 <0.001
 Dmean (Gy) 0.85 ± 0.20 0.81 ± 0.10 5.05 ± 1.56 3.49 ± 1.20 3.71 ± 0.67 <0.001
Ipsilateral lung
 Dmax (Gy) 51.50 ± 1.82 50.56 ± 1.34 45.96 ± 2.52 43.13 ± 4.32 44.26 ± 3.15 <0.001
 Dmean (Gy) 7.66 ± 2.50 7.49 ± 2.44 12.18 ± 3.21 4.93 ± 1.45 11.71 ± 3.47 <0.001
 V5 (%) 19.80 ± 7.12 12.93 ± 4.70 79.92 ± 13.02 49.40 ± 15.51 76.38 ± 20.37 <0.001
 V10 (%) 15.21 ± 5.05 15.22 ± 5.22 44.26 ± 20.71 20.92 ± 6.58 40.30 ± 16.07 <0.001
 V20 (%) 12.99 ± 4.60 12.93 ± 4.70 15.64 ± 7.37 6.91 ± 2.03 14.69 ± 5.52 0.005
Contralateral lung
 Dmax (Gy) 1.52 ± 0.38 1.58 ± 0.37 11.67 ± 3.30 11.49 ± 4.22 6.25 ± 1.30 <0.001
 Dmean (Gy) 0.35 ± 0.08 0.35 ± 0.08 3.69 ± 1.13 2.46 ± 0.96 2.50 ± 0.57 <0.001
 V5 (%) 0.0 ± 0.0 0.0 ± 0.0 25.75 ± 18.43 14.16 ± 11.82 2.46 ± 4.55 <0.001
 V10 (%) 0.0 ± 0.0 0.0 ± 0.0 1.73 ± 2.27 1.41 ± 2.43 0.0 ± 0.0 0.016
Contralateral breast
 Dmax (Gy) 2.53 ± 0.91 2.66 ± 0.99 7.90 ± 2.76 9.68 ± 1.88 9.58 ± 2.99 <0.001
 Dmean (Gy) 0.54 ± 0.14 0.53 ± 0.14 2.69 ± 0.78 2.96 ± 0.57 2.19 ± 0.49 <0.001
 V3 (%) 0.16 ± 0.31 0.17 ± 0.36 27.87 ± 15.98 48.72 ± 15.42 17.80 ± 8.79 <0.001
 V5 (%) 0.0 ± 0.0 0.0 ± 0.0 6.25 ± 6.98 14.54 ± 7.06 3.84 ± 3.87 <0.001
Body-PTV
 V3 (%) 7.81 ± 3.35 7.86 ± 3.05 51.98 ± 11.50 39.30 ± 10.30 40.77 ± 9.68 <0.001
 V5 (%) 5.76 ± 2.38 5.73 ± 2.23 34.57 ± 9.10 27.19 ± 8.31 25.79 ± 7.98 <0.001
 V10 (%) 4.53 ± 1.96 4.52 ± 1.88 15.32 ± 4.46 13.86 ± 4.66 11.69 ± 4.11 <0.001
 V20 (%) 3.45 ± 1.62 3.41 ± 1.59 4.91 ± 1.68 5.95 ± 2.24 4.67 ± 1.91 0.016
 V30 (%) 2.80 ± 1.43 2.77 ± 1.42 1.92 ± 0.88 2.39 ± 1.07 1.66 ± 0.85 0.124
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clinical irradiation patterns have shifted from conventional 2D therapy to a more devel-
oped 3D therapy based on CT for the curative management of breast cancer (Haffty 
et al. 2008). Breast irradiation has been shown to decrease the risk of local recurrence 
after breast-conserving surgery with few adverse effects (Fisher et al. 2002). One of the 
most concerning complications of breast radiotherapy is cardiotoxicity from radiation 
to the heart. Early studies showed decreased left ventricular function in breast cancer 
patients treated with radiation (Wehr et al. 1982). Therefore, several broad categories of 
techniques to reduce cardiac radiation doses were developed. These techniques include 
breath holding techniques, prone positioning, and two-tangential or multi-beam IMRT. 
However, this manuscript focused solely on beam arrangement to decrease the radiation 
to the heart, LAD, and contralateral breast for women receiving radiation to the right 
breast.
A very recent study on “Risk of Ischemic Heart Diseases in Women after Radiother-
apy for Breast Cancer” by Sarah CD et  al. suggests that the exposure of heart to ion-
izing radiations during radiotherapy for breast cancer increases the subsequent rate of 
ischemic heart diseases. The increase is proportional to the mean dose to heart, begins 
within few years after exposure, and continues at least for 20 years. Woman with preex-
isting cardiac risk factors have greater absolute increase in risk from radiotherapy than 
other women. Also, the rate of major coronary events increased linearly with the mean 
dose to the heart by 7.4 % per Gray, with no apparent threshold. The risk starts within 
5  years after radiotherapy and continuous up to the third decade after radiotherapy 
(Darby et al. 2013). In our study the mean dose that heart receives were about 1 Gy for 
both 3DCRT and for-IMRT. The heart doses for inv-IMRT, HT, VMAT were 5.10, 3.74 
and 4.99 Gy respectively. Therefore heart dose should be taken into consideration while 
planning the appropriate technic for right breast irradiation.
There are several published studies on the various techniques to decrease heart irra-
diation in women treated for left-sided breast cancer (Mayo et al. 2005; Schubert et al. 
2011; Haciislamoglu et al. 2015), but relatively little published experience exists for the 
right breast. The objective of this study was to compare the dosimetric characteristics of 
IPMB (inv-IMRT, HT and VMAT) and FPTF (3DCRT and for-IMRT) techniques and to 
evaluate the characteristics of each modality when applied to the whole right breast in 
the early stage of the breast cancer.
In this study, IPMB modalities performed better than FPTF techniques for right-sided 
breast cancer in several respects. First, IPMB modalities provided superior dose homo-
geneity and conformity of PTV (except for HI of VMAT). Additionally, IPMB modalities 
showed a reduction in Dmax, Dmean and V53.5. The reduction of maximum breast and skin 
doses harbors clinical relevance because it relates to acute skin toxicity, long-term fibro-
sis and adverse cosmetic outcomes. Meanwhile, IPMB modalities increase the contralat-
eral OAR volumes receiving exposure. Contrary to the left breast, contralateral OARs 
include the heart and LAD on right breast. Prolonged follow-up showed an increased 
RT-induced risk of cardiac events and secondary lung and breast cancer in long-term 
survivors (Darby et  al. 2011; Henson et  al. 2013). Moreover, according to the Ashraf 
et al. recent study on “Comparative Study of 3DCRT versus IMRT in Post lumpectomy 
Early Stage Breast Cancer Patients”, 3DCRT reduces the risk of radiation-induced heart 
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diseases by a factor of about 9.62 in right-sided breast diseases compared to IMRT, and 
by a factor of 1.27 in left-sided breast diseases (Ashraf et al. 2014).
When we consider IMRT as a replacement for conventional treatment, two factors 
must be taken into account: (1) more monitor units are used, which results in a larger 
total-body radiation dose and (2) more fields are used, which results in a larger volume 
of normal tissue exposed to lower radiation doses (Hall and Wuu 2003; Kry et al. 2005). 
Some machines leak a little more than others, but the overall conclusion is that IMRT 
may approximately double the induced-cancer rate compared with conventional treat-
ment. Compared with three dimensional conformal RT (3D-CRT), IMRT may double 
the incidence of solid cancers in long-term survivors because of a combination of the 
increase in monitor units and the changed dose distribution. The importance of a larger 
volume of normal tissue exposed to lower radiation doses depends on the shape of the 
dose–response relationship for radiation-induced carcinogenesis. Therefore, strategies 
for OARs, while maintaining adequate dose coverage of the target, are warranted. In our 
study, compared to IPMB modalities, FPTF modalities showed smaller exposed volumes 
of the heart, LAD, ipsilateral lung, contralateral lung, and breast.
Among IPMB modalities performed with respect to conservative surgery, HT pro-
vides better dose homogeneity and conformity of PTV, decreases the heart and LAD 
volumes receiving higher and lower doses (except for Dmax of LAD), and has the distinc-
tive advantage of target coverage compared with the inv-IMRT and VMAT. In our study 
of HT, the virtual structure for the dose constraint was contoured for each patient to 
decrease the dose to the heart and LAD, and this virtual structure volume was optimized 
similarly to that done for the left breast. During optimization, the dose to the virtual 
structure was reduced by setting higher dose constraints to reduce the doses to the heart 
and LAD. On the contrary, HT decreases the OAR volumes receiving higher doses with 
an increase in the volumes receiving low doses. These effects are probably due to more 
scattered irradiation, which is known to lead to an increased rate of radiation-induced 
coronary heart disease and secondary malignancies, such as cancer of the contralateral 
breast. HelicalTomotherapy technique where a continuous helical beam trajectory was 
used for this study. The TomoDirect treatment delivery technique uses two or more 
fixed gantry angles, as distinct from the Helical Tomotherapy. TomoDirect delivery is 
able to create a dose distribution very similar to that resulting from fixed-gantry 3DCRT 
and for-IMRT, wedged, or compensated beam techniques used with a conventional lin-
ear accelerator. Further work should be carried out to investigate the potential benefits 
of TomoDirect beam configurations other than simple opposed tangents.
This study suggests that IPMB reduced the maximum dose to the target volume over 
that achieved by FPTF; the maximum doses to ipsilateral OARs were reduced as well. 
However, 3DCRT and for-IMRT techniques were superior in terms of minimizing the 
dose to normal tissues, the dose to the heart, LAD, contralateral breast, and treatment 
time. Particularly, consequences of heart and LAD doses would have to be weighed 
against the benefits of reducing high doses on individual patient selection basis for the 
right breast. Therefore, the dosimetric superiority of IPMB modalities over FPTF modal-
ities for right-sided breast cancer remains questionable, and patient-specific conditions 
should be included in the evaluation of which right-sided breast cancer patients may 
benefit from multi-beam inverse-planned IMRT.
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As a result, the quality of the treatment plan depends on many factors. In general, for 
every patient, there is an optimum plan that treats the breast tissue while sparing the 
organs at risk. However, the technique one uses could vary depending on patient geom-
etry or the technology available in the radiotherapy center, including the available treat-
ment planning systems, beam energy, TPS algorithm, and the skills of the planner (Lu 
2013; Rana 2014).
Conclusions
For patients with right-sided breast cancer, IPMB modalities demonstrated clear advan-
tage over 3DCRT and for-IMRT in target coverage and conformity. IPMB modalities 
decrease the ipsilateral OAR volumes receiving high doses, but increase the volumes 
receiving low doses. Additionally, IPBM modalities result in an increase in Dmax, Dmean, 
and volumes receiving low doses for contralateral critical organs. The breath-hold tech-
nique resulted in a significant reduction in radiation dose to the heart and LAD com-
pared with an free breathing technique for left breast radiotherapy. In our study we also 
found that 3DCRT and for-IMRT showed dosimetric benefit in right sided breast cancer. 
This dosimetric benefit was both useful for LAD and heart doses. The anatomic localiza-
tion of the heart may cause this benefit even in the absence of breath hold technics. We 
infer from this study that treatment technique selection is an important factor in whole 
breast irradiation for both left and right breast cancers.
The IMRT plans contribute a modestly higher dose to adjacent healthy tissues. The 
main concern of with the healthy soft tissue dose increases of such magnitude is an 
increased risk of late secondary malignancy. Further, clinic studies designed to clarify 
uncertain as side effects and second primary tumors for right-sided breast irradiation 
should be performed in future.
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